{
  "docId": "019de071-805e-75da-a9c3-e9573cb6e94f",
  "docSlug": "f179c2894ff7ef65a3c6d24dd4bec442",
  "documentTitle": "Exscientia | IPO Presentation Deck | 60 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7893755,
  "pageNumber": 2,
  "pageCount": 60,
  "prevPage": 1,
  "nextPage": 3,
  "slideType": "appendix_data",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-805e-75da-a9c3-e9573cb6e94f/2",
  "deckHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f",
  "deckJsonHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f.json",
  "deckAnchorHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f#slide-2",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.6,
        "x": 0.35,
        "y": 0.38
      },
      "kind": "list",
      "text": "To fund development of the company's proprietary technology platform; To fund research and development related to the company's EXS21546 clinical candidate; To fund research and development related to the company's ongoing discovery programmes; To fund research and discovery with respect to the company's ongoing and future projects; For working capital and general corporate purposes.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9fc8ae3e-d601-4ab1-ac95-6109198c01cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "table",
      "text": "Issuer: Exscientia Limited; Ticker / Exchange: EXAI / NASDAQ; Base Offering Size: 13,095,238 ADSs; Options: 1,964,285 ADSs; Ratio: 1:1; Price Range: $20.00 - $22.00; Use of Proceeds: R&D, platform, working capital; Bookrunners: GS, MS, BofA, Barclays",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbee170b-793b-4c8d-b610-45d1077eb3cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.3,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Offering Summary",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "acbff143-6e7c-4a08-acfd-29fd0e000ef7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}